SYNETS Trademark

Trademark Overview


On Friday, February 3, 2023, a trademark application was filed for SYNETS with the United States Patent and Trademark Office. The USPTO has given the SYNETS trademark a serial number of 97779299. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2024. This trademark is owned by Biogency Pty Ltd. The SYNETS trademark is filed in the Pharmaceutical Products category with the following description:

Food supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiova...
synets

General Information


Serial Number97779299
Word MarkSYNETS
Filing DateFriday, February 3, 2023
Status700 - REGISTERED
Status DateTuesday, July 30, 2024
Registration Number7459948
Registration DateTuesday, July 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and ServicesFood supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiogency Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAlexandria NSW,2015
AU

Party NameBiogency Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAlexandria NSW,2015
AU

Party NameBiogency Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAlexandria NSW,2015
AU

Trademark Events


Event DateEvent Description
Wednesday, November 8, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 7, 2023NEW APPLICATION ENTERED
Wednesday, February 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 1, 2023ASSIGNED TO EXAMINER
Wednesday, November 8, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, November 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 8, 2023EXAMINER'S AMENDMENT ENTERED
Sunday, November 12, 2023SUSPENSION LETTER WRITTEN
Sunday, November 12, 2023LETTER OF SUSPENSION E-MAILED
Sunday, November 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 17, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 9, 2024ASSIGNED TO LIE
Tuesday, April 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED